Abstract
VEGF(121), the 121-amino acid form of vascular endothelial growth factor is a homodimer with nine cysteine residues per monomer. While three intramolecular and two intermolecular disulfide bonds have been mapped, the state of the ninth cysteine, Cys116, is not known. In this study, we determined that human VEGF(121) contains a third interchain disulfide bond between Cys116 of each monomer. We also isolated a VEGF(121) variant with two extra cysteines bound to each Cys116. No evidence was found for the exsistence of Cys116 in the reduced state. In fact, selective reduction of the Cys116 interchain disulfide bond yielded an unstable VEGF(121) molecule, which reoxidized quickly. Biological activities of VEGF(121) Cys116 variants were assessed. The oxidative state of Cys116 has no effect on binding or proliferation activities but may be important for overall stability of the molecule.
MeSH terms
-
Animals
-
CHO Cells
-
Cell Division / drug effects
-
Chromatography, High Pressure Liquid
-
Cricetinae
-
Cysteine / chemistry
-
Dimerization
-
Disulfides / chemistry
-
Endothelial Growth Factors / chemistry*
-
Endothelial Growth Factors / genetics
-
Endothelial Growth Factors / pharmacology
-
Endothelium, Vascular / cytology
-
Endothelium, Vascular / drug effects
-
Genetic Variation
-
Humans
-
Lymphokines / chemistry*
-
Lymphokines / genetics
-
Lymphokines / pharmacology
-
Molecular Structure
-
Mutagenesis, Site-Directed
-
Oxidation-Reduction
-
Pichia / genetics
-
Protein Structure, Quaternary
-
Recombinant Proteins / chemistry
-
Recombinant Proteins / genetics
-
Recombinant Proteins / pharmacology
-
Vascular Endothelial Growth Factor A
-
Vascular Endothelial Growth Factors
Substances
-
Disulfides
-
Endothelial Growth Factors
-
Lymphokines
-
Recombinant Proteins
-
VEGFA protein, human
-
Vascular Endothelial Growth Factor A
-
Vascular Endothelial Growth Factors
-
Cysteine